Previous 10 | Next 10 |
Rockwell Medical Announces $15 Million At-Market Offering PR Newswire WIXOM, Mich. , May 31, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia...
Rockwell Medical, Inc. to Present at H.C. Wainwright Annual Global Life Sciences Conference PR Newswire WIXOM, Mich. , May 23, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical compa...
Rockwell Medical, Inc. (RMTI) Q1 2022 Earnings Conference Call May 16, 2022 16:15 ET Company Participants Jason Finkelstein - Investor Relations Russell Ellison - President and Chief Executive Officer Russell Skibsted - Executive Vice President, Chief Financial Officer and Chief Business Offi...
Rockwell Medical press release (NASDAQ:RMTI): Q1 GAAP EPS of -$0.84 beats by $0.15. Revenue of $16.12M (+4.2% Y/Y) misses by $1.53M. As of March 31, 2022, cash and cash equivalents and working capital totaled $9.9 million and $5.2 million, respectively. Amended and expanded supply agreement w...
Rockwell Medical Provides First Quarter 2022 Financial and Operational Update PR Newswire - First quarter net sales of $16.1 million , up 4.2% year-over-year - - Submitted Supplemental Data to FDA for IND Application to enable Phase 2 FPC Home Infusion Tria...
ADMP, ALBO, ANY, AREC, ASTS, AXDX, CCSI, OTCQX:CWBHF, CWBR, CYRN, DAC, DADA, DNA, EGLX, FTK, FUV, GAN, GLBE, GNLN, HYRE, INPX, IONQ, IPWR, ISUN, IZEA, KBNT, KULR, MARK, MVST, OTCQB:NEXCF, NU, OTCQX:PLNHF, PPSI, PYR, QIPT, REED, REKR, RGTI, RKLB, RMTI, SHLS, OTCQX:SHWZ, SLGG, SNDL, SPI, SPRO, ...
Rockwell Medical (NASDAQ:RMTI) is scheduled to announce Q4 earnings results on Monday, May 16th, after market close. The consensus EPS Estimate is -$0.99 and the consensus Revenue Estimate is $17.65M (+16.1% Y/Y). For further details see: Rockwell Medical Q4 2021 Earnings Preview
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting off the final day of the workweek with an overview of the biggest pre-market stock movers for Friday! Source: f11photo/Shutterstock.com A statement from Elon Musk, several earnings reports, and...
Rockwell Medical (NASDAQ:RMTI) shares fell ~16% after the biopharmaceutical company announced a 1-for-11 reverse split of its issued and outstanding common stock, effective May 13, 2022. As a result, every 11 shares of the company's common stock issued and outstanding will be automa...
Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial PR Newswire WIXOM, Mich. , May 12, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transfor...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...